Purity, disgust, and intent to receive the HPV vaccine

HPV, genital warts, and purity: college-aged individuals’ perceptions of HPV and intention to receive the HPV vaccine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN27393344

Enrollment

5049

Registered

2019-01-18

Start date

2019-01-15

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intent to receive HPV vaccine Urological and Genital Diseases

Interventions

Participants will be randomized using a Qualtrics algorithm. The algorithm randomly presents either the control or experimental visual message while ensuring that control and experimental group number

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Between 18 and 23 years of age (inclusive) 2. Resident of the United States 3. Has received no more than 2 doses of the HPV vaccine

Exclusion criteria

Exclusion criteria: 1. Has completed the HPV vaccine series (3 or more doses) 2. Has already completed the survey

Design outcomes

Primary

Measure	Time frame
Intent to receive the HPV vaccine, measured once during a post-intervention survey administered immediately after the visual message has been reviewed by the participant. The method of measurement for the primary outcome is a single question asking if the participants intends to initiate (if they have received 0 HPV vaccine doses) or continue (if they have received 1-2 HPV vaccine doses) the HPV vaccine series.	—

Measure

Time frame

Intent to receive the HPV vaccine, measured once during a post-intervention survey administered immediately after the visual message has been reviewed by the participant. The method of measurement for the primary outcome is a single question asking if the participants intends to initiate (if they have received 0 HPV vaccine doses) or continue (if they have received 1-2 HPV vaccine doses) the HPV vaccine series.

—

Secondary

Measure	Time frame
Clicks on a link helping to locate the nearest vaccine clinic, measured using embedded data in the online survey administered immediately after the visual message has been reviewed by the participant.	—

Countries

United States of America

Contacts

Public ContactAvnika Amin

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026